Analysts at Robert W. Baird started coverage on shares of Elevance Health (NYSE:ELV – Get Free Report) in a report released on Thursday, Marketbeat reports. The firm set an “outperform” rating and a $649.00 price target on the stock. Robert W. Baird’s price target would suggest a potential upside of 20.53% from the stock’s previous […]